1202044-20-9 Usage
Use
Ostarine, also known as?ostarine MK-2866,?is an investigational?selective androgen receptor modulator?(SARM) developed by?GTx, Inc.?for the treatment of conditions such as?muscle wasting?and?osteoporosis.
Mechanism
Ostarine(MK-2866) attaches to proteins in the body known as androgen receptors. When ostarine binds to these receptors, it tells the muscles in the body to grow. Unlike some other chemicals that bind to androgen receptors, such as?steroids, ostarine doesn't seem to cause as many side effects in other parts of the body.
Health effects
The FDA have warned that SARMs can have serious side effects ranging from risk of heart attack to stroke and liver damage.
Description
Ostarine is an investigational drug that has not yet been approved by the US Food and Drug Administration (FDA). It is part of a class of drugs called selective androgen receptor modulators (SARMs).
Uses
(2S)-3-(4-Cyanophenoxy-2,3,5,6-d4)-N-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamide is a metabolites of selective androgen receptor modulators (SARM).
Check Digit Verification of cas no
The CAS Registry Mumber 1202044-20-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,0,2,0,4 and 4 respectively; the second part has 2 digits, 2 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 1202044-20:
(9*1)+(8*2)+(7*0)+(6*2)+(5*0)+(4*4)+(3*4)+(2*2)+(1*0)=69
69 % 10 = 9
So 1202044-20-9 is a valid CAS Registry Number.
InChI:InChI=1/C19H14F3N3O3/c1-18(27,11-28-15-6-2-12(9-23)3-7-15)17(26)25-14-5-4-13(10-24)16(8-14)19(20,21)22/h2-8,27H,11H2,1H3,(H,25,26)/t18-/m1/s1
1202044-20-9Relevant articles and documents
METABOLITES OF SELECTIVE ANDROGEN RECEPTOR MODULATORS AND METHODS OF USE THEREOF
-
Page/Page column 123, (2010/01/12)
This invention provides metabolites of SARM compounds including inter alia glucuronidated metabolites and uses thereof in treating a variety of diseases or conditions in a subject, including, inter alia, muscle wasting disease and/or disorder, a bone related disease and/or disorder, metabolic syndrome, diabetes and associated diseases, and others.
